Results 301 to 310 of about 59,639 (336)
Some of the next articles are maybe not open access.
Status Epilepticus, Refractory Status Epilepticus, and Super-refractory Status Epilepticus
CONTINUUM: Lifelong Learning in Neurology, 2018ABSTRACT PURPOSE OF REVIEW Status epilepticus, refractory status epilepticus, and super-refractory status epilepticus can be life-threatening conditions. This article presents an overview of the three conditions and discusses their management and outcomes.
Panayiotis N. Varelas, Sarah E. Nelson
openaire +3 more sources
Journal of Palliative Medicine, 2004
A31-YEAR-OLD COMPUTER CONSULTANT was admitted to the hospital for intractable nausea and vomiting. He had presented 18 months earlier with a perforated bowel after a long history of Crohn’s disease. At surgical exploration he was found to have a perforated appendiceal cancer with omental and peritoneal metastases treated with a right hemicolectomy and ...
M. Golf+5 more
openaire +3 more sources
A31-YEAR-OLD COMPUTER CONSULTANT was admitted to the hospital for intractable nausea and vomiting. He had presented 18 months earlier with a perforated bowel after a long history of Crohn’s disease. At surgical exploration he was found to have a perforated appendiceal cancer with omental and peritoneal metastases treated with a right hemicolectomy and ...
M. Golf+5 more
openaire +3 more sources
Current Opinion in Critical Care, 2012
Refractory status epilepticus (RSE) has a high morbidity and mortality. There are currently no definitive data to guide both the optimal choice of therapy and treatment goals. This review focuses on RSE diagnosis and outcome and discusses both commonly used and anecdotal therapies for RSE.The challenges in performing randomized controlled trials (RCTs)
Jan Claassen, Andres Fernandez
openaire +2 more sources
Refractory status epilepticus (RSE) has a high morbidity and mortality. There are currently no definitive data to guide both the optimal choice of therapy and treatment goals. This review focuses on RSE diagnosis and outcome and discusses both commonly used and anecdotal therapies for RSE.The challenges in performing randomized controlled trials (RCTs)
Jan Claassen, Andres Fernandez
openaire +2 more sources
Neurology, 2022
Background and Objectives Refractory status epilepticus (RSE) bears significant morbidity and mortality. Therapy escalation and in some cases intubation are recommended. Most existing studies are retrospective and focus on intensive care units.
I. Beuchat+10 more
semanticscholar +1 more source
Background and Objectives Refractory status epilepticus (RSE) bears significant morbidity and mortality. Therapy escalation and in some cases intubation are recommended. Most existing studies are retrospective and focus on intensive care units.
I. Beuchat+10 more
semanticscholar +1 more source
International Journal of Neuroscience, 2022
Objective We aim to describe use of electroconvulsive therapy (ECT) to treat super refractory status epilepticus (SRSE) in pregnancy and review the literature regarding utility and safety of ECT in refractory status epilepticus.
L. Singla+4 more
semanticscholar +1 more source
Objective We aim to describe use of electroconvulsive therapy (ECT) to treat super refractory status epilepticus (SRSE) in pregnancy and review the literature regarding utility and safety of ECT in refractory status epilepticus.
L. Singla+4 more
semanticscholar +1 more source
Status epilepticus: Refractory and super-refractory
Neurology India, 2017Status epilepticus (SE) is an important neurological emergency. It is defined as seizures lasting for 5 minutes or more or recurrent seizures without recovery of consciousness to baseline between the attacks. Refractory SE (RSE) is defined as SE persisting despite sufficient dose of benzodiazepines and at least one antiepileptic drug (AED ...
Deepanshu Dubey+2 more
openaire +3 more sources
Second‐line immunotherapy in new onset refractory status epilepticus
EpilepsiaSeveral pieces of evidence suggest immune dysregulation could trigger the onset and modulate sequelae of new onset refractory status epilepticus (NORSE), including its subtype with prior fever known as febrile infection‐related epilepsy syndrome (FIRES).
A. Hanin+2 more
semanticscholar +1 more source
Epilepsia
Febrile infection‐related epilepsy syndrome (FIRES) is a subset of new onset refractory status epilepticus (NORSE) that involves a febrile infection prior to the onset of the refractory status epilepticus.
Anthony D. Jimenez+43 more
semanticscholar +1 more source
Febrile infection‐related epilepsy syndrome (FIRES) is a subset of new onset refractory status epilepticus (NORSE) that involves a febrile infection prior to the onset of the refractory status epilepticus.
Anthony D. Jimenez+43 more
semanticscholar +1 more source
Current Opinion in Critical Care, 2005
Although conventional anticonvulsant agents can terminate status epilepticus in most cases, a substantial minority of patients develops medically refractory status and requires more aggressive care. This review explores the options available.Increasing numbers of previously unexpected etiologies for refractory status epilepticus continue to be reported.
openaire +3 more sources
Although conventional anticonvulsant agents can terminate status epilepticus in most cases, a substantial minority of patients develops medically refractory status and requires more aggressive care. This review explores the options available.Increasing numbers of previously unexpected etiologies for refractory status epilepticus continue to be reported.
openaire +3 more sources
Neurology India, 2006
Refractory status epilepticus (RSE) is a common problem in intensive care units and emergency departments. The important risk factor predisposing patients with SE to RSE is delay in receiving treatment. Self-sustaining SE is associated with progressive, time-dependent development of pharmacoresistance.
openaire +3 more sources
Refractory status epilepticus (RSE) is a common problem in intensive care units and emergency departments. The important risk factor predisposing patients with SE to RSE is delay in receiving treatment. Self-sustaining SE is associated with progressive, time-dependent development of pharmacoresistance.
openaire +3 more sources